期刊文献+

PCR-RFLP检测载脂蛋白CⅢ基因T-455C多态性方法的建立及应用 被引量:5

Establishment of PCR-RFLP for detection of apolipoprotein CⅢ T-455C polymorphism and its application
下载PDF
导出
摘要 目的建立聚合酶链反应-限制性片段长度多态性技术(PCR-RFLP)检测载脂蛋白CⅢ(apoCⅢ)T-455C多态性的方法,探讨南通汉族人群中apoCⅢ多态性与高三酰甘油血症(HTG)的相关性。方法用PCR扩增apoCⅢ基因启动子区包含T-455C多态性在内的DNA片段,扩增产物用限制性内切酶BseGⅠ酶切后电泳,分析apoCⅢ基因型,同时采用生化方法检测研究对象的血脂和载脂蛋白水平。结果检测到3种基因型,分别为-455TT、-455TC和-455CC。HTG患者组和健康对照组apoCⅢ-455C等位基因频率(50.44%比33.11%)和apoCⅢ-455CC基因型频率(26.55%比12.16%)均有显著差异(P<0.01);C等位基因携带者患HTG的风险是非携带者的2.06倍(95%CI:1.31~3.24);-455C等位基因携带者有较高的三酰甘油(TG)和apoCⅢ蛋白水平(P<0.05)。结论PCR-RFLP是一种快速、敏感的分析apoCⅢ基因启动子区T-455C多态性的方法;apoCⅢ-455C等位基因与HTG的发生相关。 Objective To establish a method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to analyze the polymorphism of apolipoprotein C Ⅲ ( apoC Ⅲ) T-455C and to investigate the association of apo C Ⅲ T-455C polymorphism with hypertriglyceridemia(HTG) susceptibility. Methods Polymerase chain reaction (PCR) was performed to amplify apoC Ⅲ including T-455C polymorphism. PCR products were digested with restriction endonuclease, apoC Ⅲ genotype was analyzed after electrophoresis: The levels of serum lipid and apolipoprotein (apo) profiles were also studied by biochemical methods. Results The three kinds of genotypes at apoCⅢ -455 locus detected were -455TT, -455TC and -455CC. The frequencies of -455C allele (50.44% vs 33.11% in HTG patients and healthy subjects group respectively) and the -455CC genotype (26.55% vs 12.16% ) of apoCⅢ were significantly differ- ent in statistics. Compared with the T allele, the C allele had a significantly increased HTG risk ( OR = 2.06, 95% CI : 1.31 to 3.24):. The carriers with minor allele of -455C bad higher levels of serum TG and apoC Ⅲ. Conclusions PCR-RFLP is a sensitive and rapid method to investigate apo C Ⅲ gene promoter T-455C polymorphism, The apoCⅢ -455C allele might contribute to an increased risk of HTG among Chinese population.
出处 《临床检验杂志》 CAS CSCD 北大核心 2007年第4期276-279,共4页 Chinese Journal of Clinical Laboratory Science
基金 南通市社会发展基金(S2006031)
关键词 载脂蛋白CⅢ 多态性 聚合酶链反应-限制性片段长度多态性 高三酰甘油血症 Apolipoprotein C Ⅲ polymorphism polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) hy- pertriglyceridemia
  • 相关文献

参考文献8

  • 1Li W W,Dammerman M M,Smith J D,et al.Common genetic variation in the promoter of the human apoCⅢ gene abolishes regulation by insulin and may contribute to hypertriglyceridemia[J].J Clin Invest,1995,96(6):2601-2605.
  • 2刘瑞,白怀,刘宇,黄明慧,刘秉文.中国人内源性高甘油三酯血症患者载脂蛋白CⅢ基因SstⅠ酶切位点多态性的研究[J].华西医科大学学报,2001,32(2):175-178. 被引量:11
  • 3Ito Y,Azrolan N,OConneⅡ A,et al.Hypertriglyceridemia as a result of human apo C-Ⅲ gene expression in transgenie mice[J].Science,1990,249(4790):790-793.
  • 4Maeda N,Li H,Lee D,et al.Targeted disruption of the apolipoprotein C-Ⅲ gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia[J].J Biol Chem,1994,269(38):23610-23616.
  • 5Olivieri O,Bassi A,Stranieri C,et al.Apolipoprotein C-Ⅲ,metabolic syndrome,and risk of coronary artery disease[J].J Lipid Res,2003,44(12):2374-2381.
  • 6Guettier J M,Georgopoulos A,Tsai M Y,et al.Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-Ⅲ genes are associated with the metabolic syndrome and dyslipidemia in a south indian population[J].J Clin endocrinol metab,2005,90(3):1705-1711.
  • 7Miller M,Rhyne J,Khatta M,et al.Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian Indians[J].Am J Cardiol,2001,87(2):220-221.
  • 8Fruchart J C,Duriez P.Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism[J].Drugs Today,2006,42(1):39-64.

二级参考文献9

  • 1刘秉文 曾成林.内源性高甘油三酯血症发病机制探讨[J].中国动脉硬化杂志,1993,1(1):67-68.
  • 2刘秉文 王克勤.血浆载脂蛋白的免疫测定及应用.脂蛋白与动脉粥样硬化[M].北京:人民卫生出版社,1995.359-376.
  • 3Hong S H,Clin Chem,1997年,43卷,1期,13页
  • 4Bai H,Human Genet,1995年,95卷,1期,102页
  • 5Li W W,J Clin Invest,1995年,96卷,6期,2601页
  • 6刘秉文,脂蛋白与动脉粥样硬化,1995年,359页
  • 7刘秉文,中国动脉硬化杂志,1993年,1卷,1期,67页
  • 8张秋萍,刘秉文,刘宇,范萍,张荣爵,李载权,吴兆丰,傅明德,DavidJ.Galton.中国人内源性高甘油三酯血症与载脂蛋白CⅢ基因Sst Ⅰ酶切位点多态性关联的研究[J].中华医学遗传学杂志,1997,14(4):207-210. 被引量:9
  • 9刘秉文.血浆甘油三酯与动脉粥样硬化[J].心血管病学进展,1999,20(1):3-6. 被引量:45

共引文献10

同被引文献48

  • 1毕楠,鄢盛恺,李国平,尹志农,薛红,吴刚,陈保生.冠心病患者载脂蛋白A5和载脂蛋白C3基因多态性的研究[J].中华心血管病杂志,2005,33(2):116-121. 被引量:47
  • 2陈建忠.DNA测序中的毛细管凝胶电泳技术[J].医疗设备信息,2005,20(1):42-43. 被引量:3
  • 3李国平,陈保生,薛红,曾武威,吴刚.载脂蛋白C3基因多态性-482C>T与血浆脂质的关系[J].中国动脉硬化杂志,2005,13(3):335-339. 被引量:12
  • 4Ito Y, Azrolan N, O'Connell A, et al. Hypertriglyceridemia as a result of human apo C-Ⅲ gene expression in transgenic mice[J].Science, 1990, 249:790.
  • 5Maeda N,Li H,Lee D,et al. Targeted disruption of the apolipoprotein C-Ⅲ gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia[ J]. J Biol Chem, 1994,269: 23610.
  • 6Li WW, Dammerman MM, Smith JD, et al. Common genetic variation in the promoter of the human apoCⅢ gene abolishes regulation by insulin and may contribute to hypertriglyceridemia[J]. J Clin Invest, 1995,96 ( 6 ) : 2601.
  • 7Miller M, Rhyne J, Khatta M, et al. Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian Indians[J]. Am J Cardiol, 2001,87(2) :220.
  • 8Olivieri O, Bassi A, Stranieri C, et al. Apolipoprotein C-Ⅲ, metabolic syndrome, and risk of coronary artery disease [ J ]. J Lipid Res, 2003,44 (12) : 2374.
  • 9Guettier J, Georgopoulos A, Michael Y, et al. Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-Ⅲ Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population [ J ]. J Clin Endocrinol Metab, 2005,90 ( 3 ) : 1705.
  • 10Brown S, Ordovas JM, Campos H. Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins[ J ]. Atherosclerosis, 2003,170 ( 2 ) : 307.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部